5:30 PM
 | 
Oct 11, 2012
 |  BC Extra  |  Company News

GSK pledges to release detailed data to researchers

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it will release anonymized patient-level data from clinical trials to researchers wanting to use the data for a "valid scientific endeavor." Starting in January 2013, researchers will be able to request access to patient-level data collected from GSK's globally conducted Phase I-IV trials since 2007. GSK did not say what...

Read the full 260 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >